KA
NVO

Kovack Advisors’s Novo Nordisk NVO Stock Holding History

Kovack Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$209K Buy
5,713
+1,751
+44% +$83K 0.01% 913
2025
Q4 		$202K Sell
3,962
-147
-4% -$7.52K 0.01% 945
2025
Q3 		$228K Buy
+4,109
New +$241K 0.02% 535
2025
Q1 		– Sell
-4,798
Closed -$413K – 617
2024
Q4 		$413K Sell
4,798
-1,225
-20% -$132K 0.04% 357
2024
Q3 		$717K Sell
6,023
-392
-6% -$52.3K 0.08% 225
2024
Q2 		$916K Buy
6,415
+106
+2% +$14K 0.1% 177
2024
Q1 		$810K Buy
+6,309
New +$751K 0.1% 173

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Kovack Advisors's NVO Position: Q1 2026 in Review

Kovack Advisors increased its Novo Nordisk (NVO) stake by 44% in Q1 2026, buying an estimated $83K and bringing the position to 5,713 shares worth $209K. The position accounts for 0.01% of the portfolio, ranked #913.

Kovack Advisors first reported a position in NVO in Q1 2024 and has held it in 7 quarters since. The position peaked at $916K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Kovack Advisors held 5,713 shares of Novo Nordisk worth $209K as of Q1 2026.
  • Kovack Advisors bought 1,751 Novo Nordisk shares in Q1 2026, an estimated $83K.
  • Novo Nordisk made up 0.01% of Kovack Advisors's portfolio in Q1 2026, its #913 holding.
  • Kovack Advisors first reported a position in Novo Nordisk in Q1 2024 and has held it in 7 quarters since.
  • Kovack Advisors's Novo Nordisk position peaked at $916K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.